The use of a novel method of measuring blood flow to foot wounds in diabetic patients with aim of predicting wound healing

• Register: ANZCTR
• Last refreshed on: 11 June 2018
• Main ID: ACTRN12618000573257
• Date of registration: 16/04/2018
• Prospective Registration: Yes
• Primary sponsor: Guilherme Pena
• Public title: The use of a novel method of measuring blood flow to foot wounds in diabetic patients with aim of predicting wound healing
• Scientific title: The use of Siemens Syngo Parenchymal Blood Volume (PBV) during revascularisation of diabetic patients with foot tissue loss to predict likelihood of wound healing
• Date of first enrolment: 4/06/2018
• Target sample size: 50
• Recruitment status: Not yet recruiting
• URL: http://www.anzctr.org.au/ACTRN12618000573257.aspx
• Study type: Interventional
• Study design: Non-randomised trial
• Phase: Not Applicable

Health Condition(s) or Problem(s) studied

Diabetic foot

Peripheral Vascular Disease

Intervention(s)

The study proposes the use of a Parenchymal blood volume (PBV) software to obtain more detailed information about perfusion to the foot in diabetic patients with foot wounds. Participation will entail answering a questionnaire specific designed for the study) and undergoing lower limb angiogram in which the Siemens Syngo PBV software will be used. It is important to emphasize that all included patients would undergo angiogram regardless of the study and that the participation on the study will allow the use of Siemens PBV software as adjunct during revascularisation and to have wound photos taken prior to revascularisation and during follow-up appointments. PBV will be correlated with wound healing and non-invasive perfusion measurement techniques, namely toe pressure (TP) and transcutaneous oxygen pressure (TCPO2).